Skip to content

Cue Biopharma, Inc.

CUE

CIK 0001645460

← back to feed
Revenue (TTM)
$11.21M
+195.7% YoY Q1 May 2026
Net Income (TTM)
−$33.37M
+34.6% YoY Q1 May 2026
EPS Diluted (TTM)
−$6.19
+61.1% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-302.2%
Q1 May 2026
Net Margin
-297.6%
Q1 May 2026
Free Cash Flow (TTM)
−$40.06M
Q1 May 2026
Cash
$16.38M
Q1 May 2026
Total Debt
$100K
Q1 May 2026
Shares Outstanding
4.05M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings